1. Home
  2. TYGO vs RFL Comparison

TYGO vs RFL Comparison

Compare TYGO & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tigo Energy Inc.

TYGO

Tigo Energy Inc.

HOLD

Current Price

$1.10

Market Cap

129.0M

Sector

Technology

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

N/A

Current Price

$2.61

Market Cap

133.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TYGO
RFL
Founded
2007
2017
Country
United States
United States
Employees
N/A
23
Industry
Semiconductors
Real Estate
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
129.0M
133.1M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
TYGO
RFL
Price
$1.10
$2.61
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
1.5M
92.9K
Earning Date
05-05-2026
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
97.12
28.28
EPS
0.01
N/A
Revenue
$103,536,000.00
$917,000.00
Revenue This Year
$30.78
N/A
Revenue Next Year
$21.68
N/A
P/E Ratio
$111.00
N/A
Revenue Growth
91.68
43.96
52 Week Low
$0.93
$1.12
52 Week High
$5.33
$3.96

Technical Indicators

Market Signals
Indicator
TYGO
RFL
Relative Strength Index (RSI) 35.93 62.84
Support Level $0.93 $1.21
Resistance Level $1.73 $3.96
Average True Range (ATR) 0.07 0.17
MACD 0.03 0.06
Stochastic Oscillator 44.00 82.67

Price Performance

Historical Comparison
TYGO
RFL

About TYGO Tigo Energy Inc.

Tigo Energy Inc provides solar and energy storage solutions, including module level power electronics (MLPE) designed to maximize the energy output of individual solar modules, delivering more energy, active management, and enhanced safety for utility, commercial, and residential solar arrays. By combining its MLPE and solar optimizer technology with intelligent, cloud-based software capabilities, the Company enables developed energy monitoring, system diagnostics, and real-time control. Geographically the company generates revenue from EMEA, Americas, and APAC.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: